LEOVAL INYECTABLE

Antiepileptic

Levetiracetam

Composition

Each vial of 5 mL of solution contains:
Levetiracetam 500 mg
Excipients q.s.

Presentations

Pack containing 10 vials of 5 mL

Indications

LEOVAL is indicated as monotherapy in the treatment of partial onset seizures, with or without secondary generalization in adults and adolescents over 16 years of age with a new diagnosis of epilepsy.

LEOVAL is indicated as concomitant therapy:
- In the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children over 4 years of age with epilepsy.
- In the treatment of myoclonic seizures in adults and adolescents over 12 years of age with Juvenile Myoclonic Epilepsy.
- In the treatment of primary generalized tonic-clonic seizures in adults and adolescents over 12 years of age with Generalized Idiopathic Epilepsy.

Levetiracetam concentrate is an alternative for patients in whom oral administration is temporarily not feasible.